Moreover, in five familiar AD (5 × FAD) mice, widely used as an AD animal model, ABA treatment improved cognitive and memory impairment and decreased Aβ deposition and neuroinflammation, reducing mRNA expression levels of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IFN-γ. The gene discussed is IL1B; the disease is Alzheimer disease.